Michelle Longmire is the cofounder and CEO of Medable, a platform used by doctors and researchers running clinical trials to collect patients’ health data outside the walls of the lab. This data, which focuses on the environmental factors of health, is contributing to what Longmire calls the “Digitome,” a digital analog to the genome that represents all the elements of human health that can be found outside the genetic code. In essence, the Digitome is composed of data that reveals the way you live and how it impacts your health.
To date, Medable’s platform is being used in 6,000 clinical trials in some of the biggest hospital systems and biopharmaceutical companies in the world and has reached over 15 million patients. Within the Digitome, Longmire is using AI to look for patterns in the ways patients contract diseases and react to medication to give doctors more information about people’s health. Longmire believes the Digitome is only at about 1% of what it could be--and in the next few years she’s planning to open up Medable’s platform so that people can proactively use it themselves, adding their data to the Digitome to help researchers understand how diseases work, and how to fight them.